Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
May 12, 2019
| Rachel Schwartz
Response to 60 Minutes May 12, 2019: AAM Statement on the Importance of Competition to Promote Accessibility and Affordability of Medicines
Press Release
May 8, 2019
| Rachel Schwartz
AAM Statement on Introduction of the Affordable Prescriptions for Patients Act
Press Release
May 7, 2019
| Jeff Francer
AAM Statement: Senate Judiciary Committee Hearing on Patents and Drug Prices
Press Release
Apr 24, 2019
| Jewel Smith
AAM Announces 2019 Associate Members
Press Release
Apr 3, 2019
| Rachel Schwartz
AAM Statement on House Energy & Commerce Passage of the CREATES Act
Press Release
Apr 1, 2019
| Rachel Schwartz
AAM Response to CMS Final 2020 Call Letter
Press Release
Mar 27, 2019
| Rachel Schwartz
AAM Statement: 2019 Energy and Commerce Health Subcommittee Markup
Press Release
Mar 18, 2019
| Rachel Schwartz
Karin Hessler Joins AAM as Assistant General Counsel
Press Release
Mar 11, 2019
| Rachel Schwartz
AAM Statement in Response to Administration's FY 2020 Budget Proposal
Press Release
Mar 7, 2019
| Rachel Schwartz
AAM Statement on FDA Draft Guidance on Biosimilar Naming Requirements
Press Release
Mar 5, 2019
| Rachel Schwartz
AAM Statement on Dr. Scott Gottlieb's Departure
Press Release
Feb 28, 2019
| Rachel Schwartz
New Study Shows Seniors Paid Nearly $22 Billion in Extra Out-of-Pocket Costs for Generic Medicines
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action